recommended for detection of MAGE-A2 of human origin by WB, IP, IF, IHC(P) and ELISA
Modification Notes
The melanoma-associated antigen (MAGE) family consists of a number of antigens recognized by cytotoxic T lymphocytes. The MAGE genes were initially isolated from different kinds of tumors and, based on their virtually exclusive tumor-specific expression in adult tissues, they have been used as targets for cancer immunotherapy. MAGE genes encode for tumor-rejection antigens and are expressed in tumors of different histologic types and in normal testis and placenta. MAGE-A2 (melanoma antigen family A2), also known as MAGE2, MAGEA2A, MAGE-A2B or CT1.2 (cancer/testis antigen 1.2), is a 314 amino acid protein that contains one MAGE domain. Expressed in a variety of carcinomas, including melanoma, breast cancer, lung cancer and neck and head squamous cell carcinoma, MAGE-A2/2B is thought to play a role in embryonic development and tumor transformation/progression.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFIHCELISA
WB:1:500~1:2000 IP:1:100~1:500 IF:1:200~1:500 IHC:1:50~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
recommended for detection of MAGE-A2 of human origin by WB IP IF IHC(P) and ELISA
Tissue Specificity
recommended for detection of MAGE-A2 of human origin by WB, IP, IF, IHC(P) and ELISA